Gene Therapy Drugs Market was valued at USD 4.1 Billion in 2022 and is projected to reach USD 18.58 Billion by 2030, growing at a CAGR of 27.03% from 2024 to 2030.
The global gene therapy drugs market was valued at approximately USD 4.8 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 27.5% from 2023 to 2030. This growth is driven by advancements in genetic research, increasing prevalence of genetic disorders, and the development of innovative gene therapy technologies. The market is expanding due to significant investments in research and development and the increasing adoption of gene therapies in clinical trials and treatments. The rising incidence of rare genetic diseases and the growing demand for personalized medicine further contribute to the market’s growth.
Emerging markets present substantial opportunities for growth in the gene therapy drugs sector. Regions such as Asia-Pacific and Latin America are anticipated to experience significant growth due to improvements in healthcare infrastructure, increasing government funding, and rising awareness about gene therapies. These markets are characterized by a growing patient population and expanding healthcare access, which are expected to drive the demand for advanced gene therapy treatments. Additionally, strategic collaborations and partnerships in these regions are likely to enhance market penetration and drive innovation.
Get an In-Depth Research Analysis of the Global Gene Therapy Drugs Market Size And Forecast [2025-2032]
F. Hoffmann-La Roche AG
Novartis International AG
Gilead Sciences
Inc.
Ultragenyx Pharmaceutical，Inc.
Applied Genetic Technologies Corp
Audentes Therapeutics
BioMarin Pharmaceutical
Bluebird Bio
Nightstar Therapeutics
Sangamo Therapeutics
Spark Therapeutics
uniQure
VBL Therapeutics
Voyager Therapeutics
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Gene Therapy Drugs Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Gene Therapy Drugs Market
Hospital
Pharmacy
Based on Types the Market is categorized into Below types that held the largest Gene Therapy Drugs market share In 2023.
Neuromuscular Disease
Genetic Disease
Other
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Gene Therapy Drugs Market Research Analysis
1. Introduction of the Global Gene Therapy Drugs Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Gene Therapy Drugs Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Gene Therapy Drugs Market, By Type
6. Global Gene Therapy Drugs Market, By Application
7. Global Gene Therapy Drugs Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Gene Therapy Drugs Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/